Inventor · disambiguated record
Carla Guimaraes
Also filed as: GUIMARAES CARLA · GUIMARAES CARLA PATRICIA · GUIMARAES CARLA PATRICIA PINTO
11 granted patents·10 pending applications·51 citations·filing 2010–2024
88Inventor score
Top patents by PatentIndex Score
21 records- 0196US10525083B2Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domainNOVARTIS AG·Filed 2017·Granted Jan 7, 2020·15 cites·33 claims
- 0294US11975026B2CD19 and CD22 chimeric antigen receptors and uses thereofNOVARTIS AG·Filed 2020·Granted May 7, 2024·3 cites·23 claims
- 0394US11026976B2Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domainNOVARTIS AG·Filed 2019·Granted Jun 8, 2021·6 cites·23 claims
- 0493US11872249B2Method of treating cancer by administering immune effector cells expressing a chimeric antigen receptor comprising a CD20 binding domainNOVARTIS AG·Filed 2021·Granted Jan 16, 2024·2 cites·38 claims
- 0592US12344651B2CD19 and CD22 chimeric antigen receptors and uses thereofNOVARTIS AG·Filed 2024·Granted Jul 1, 2025·1 cites·12 claims
- 0689US8940501B2Methods for ligation and uses thereofPLOEGH HIDDE L·Filed 2010·Granted Jan 27, 2015·17 cites·21 claims
- 0780US12383601B2Chimeric antigen receptors and uses thereofNOVARTIS AG·Filed 2020·Granted Aug 12, 2025·1 cites·21 claims
- 0880US9683019B2Cyclic polypeptides for the treatment of heart failureZECRI FREDERIC·Filed 2015·Granted Jun 20, 2017·3 cites·19 claims
- 0979USRE49847ENucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding domainNOVARTIS AG·Filed 2022·Granted Feb 27, 2024·0 cites·35 claims
- 1079US11542488B2Sortase synthesized chimeric antigen receptorsNOVARTIS AG·Filed 2015·Granted Jan 3, 2023·2 cites·14 claims
- 1175US11999802B2Compositions and methods for selective protein degradationNOVARTIS AG·Filed 2018·Granted Jun 4, 2024·1 cites·33 claims
- 1271US2024384007A1Compositions and methods for selective protein degradationNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1351US2017233443A1Cyclic polypeptides for the treatment of heart failureNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1447US2014030697A1Sortase-mediated modification of viral surface proteinsMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Application pending·0 cites
- 1547US2023256017A1Methods of making chimeric antigen receptor-expressing cellsBROGDON JENNIFER·Filed 2021·Application pending·0 cites
- 1645US2023174933A1Methods of making chimeric antigen receptor-expressing cellsNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1741US2013122043A1Modified polypeptides and proteins and uses thereofGUIMARAES CARLA·Filed 2011·Application pending·0 cites
- 1840US2016166634A1Bioconjugates of synthetic apelin polypeptidesCAPLAN SHARI LYNN·Filed 2016·Application pending·0 cites
- 1938US2019375815A1Treatment of cancer using chimeric t cell receptor proteins having multiple specificitiesNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2037US2023071283A1Compositions and methods for selective protein expressionGOLOSOV ANDREI·Filed 2017·Application pending·0 cites
- 2137US2017226495A1Sortase molecules and uses thereofGUIMARAES CARLA·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →